Clinical Research Directory
Browse clinical research sites, groups, and studies.
Descemet Endothelial Thickness Comparison Trial I
Sponsor: Stanford University
Summary
Descemet Endothelial Thickness Comparison Trial (DETECT) I is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 160 patients in a 2x2 factorial design. The purpose of this study is to determine differences in visual outcomes between two types of corneal transplant surgeries, ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) and Descemet membrane endothelial keratoplasty (DMEK), and to determine the effect of rho-kinase inhibitors on endothelial cell loss.
Official title: Descemet Endothelial Thickness Comparison Trials (DETECT I & II)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2022-07-15
Completion Date
2027-11-30
Last Updated
2025-12-17
Healthy Volunteers
No
Conditions
Interventions
Topical Ripasudil
To determine the effect of rho-kinase inhibitors on endothelial cell loss
Topical Placebo
topical Placebo
Locations (7)
Stanford University
Palo Alto, California, United States
University of California Davis
Sacramento, California, United States
University of Miami
Palm Beach Gardens, Florida, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Oregon Health & Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Wills Eye Hospital
Philadelphia, Pennsylvania, United States